DNA X, Inc.
SONM
$3.94
-$0.54-12.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 7.94% | -2.83% | -0.33% | 11.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 7.94% | -2.83% | -0.33% | 11.57% |
| Cost of Revenue | -- | 33.44% | -12.06% | -39.71% | -- |
| Gross Profit | -- | -57.09% | 440.73% | 187.94% | -- |
| SG&A Expenses | 4.69% | -4.72% | 17.71% | 18.36% | -349.46% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.73% | 16.07% | -0.36% | -17.41% | -452.39% |
| Operating Income | -44.74% | -67.51% | -4.05% | 123.99% | 772.11% |
| Income Before Tax | -61.07% | -94.70% | -11.51% | 121.22% | 804.13% |
| Income Tax Expenses | -- | -23.08% | 275.68% | 5.60% | -- |
| Earnings from Continuing Operations | -58.31% | -89.21% | -12.98% | 115.76% | 776.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 58.88% | -89.21% | -12.98% | 115.76% | -1,497.49% |
| EBIT | -44.74% | -67.51% | -4.05% | 123.99% | 772.11% |
| EBITDA | -34.14% | -107.68% | -5.51% | 193.97% | 2,668.41% |
| EPS Basic | 88.46% | 48.25% | 44.34% | 111.98% | -1,383.69% |
| Normalized Basic EPS | -77.86% | 46.75% | 49.52% | 116.12% | 769.90% |
| EPS Diluted | 88.47% | 48.20% | 44.05% | 111.98% | -1,378.25% |
| Normalized Diluted EPS | -77.86% | 46.75% | 49.52% | 116.05% | 769.90% |
| Average Basic Shares Outstanding | 175.73% | 265.59% | 103.00% | 31.55% | 6.89% |
| Average Diluted Shares Outstanding | 175.73% | 265.59% | 103.00% | 32.20% | 6.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |